Overview
The purpose of this study seeks to describe the real world initial experience with sotatercept in the treatment of pulmonary hypertension.
Eligibility
Inclusion Criteria:
- Adults age 18 or greater who are being treated with sotatercept in the Mayo Pulmonary hypertension clinic.
Exclusion Criteria:
- Adults lacking capacity to consent


